A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers
Yue Hu
◽
Hong Zhang
◽
Xiaojiao Li
◽
Jiajia Mai
◽
Lizhi Yang
◽
...